home / stock / cbis / cbis news

CBIS News and Press, Cannabis Science Inc From 05/31/19

Stock Information
Company Name: Cannabis Science Inc
Stock Symbol: CBIS
Market: OTC
Menu
CBIS CBIS Quote CBIS Short CBIS News CBIS Articles CBIS Message Board
Get CBIS Alerts

News, Short Squeeze, Breakout and More Instantly...
CBIS - GHC Summit at Harvard Medical School Announces Cannabis Science as Industry Partner in the Launch of the International Phytomedicines Institute at Harvard Medical School

IRVINE, CA, May 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the research and development of cannabinoid-based medicines, is proud to announce it has been introduced as one of the key industry partners i...
CBIS - Cannabis Science Set to Participate in the Premier Event Focused on High-Impact Global Collaborations; The Global Health Catalyst Summit at Harvard Medical School Starts Today

IRVINE, CA, May 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company’s participation in the 2019 Global Health Catalyst (GHC) Summi...

CBIS - Cannabis Science Announces NFL Greats Past and Present Set to Participate and Partner With the Global Health Catalyst Summit at Harvard Medical School on May 24-26, 2019

IRVINE, CA, May 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the upcoming Global Health Catalyst (GHC) Summit at Harvard Medical School h...

CBIS - Cannabis Science and Dana-Farber Cancer Institute Sign a New Research Agreement to Investigate Proprietary Extract From Justicia Plant

IRVINE, CA, May 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, has entered into a new Research Collaboration Agreement with Dana-Farber Cancer Institute, Inc. to investigate ...
CBIS - Analyzing Some Exciting But Unknown Marijuana Stocks

The marijuana sector of the stock market has been a wild one. I first became interested in this segment in 2013, when in the midst of a growing optimism in the future of the legalised marijuana industry, we saw a huge bull run in every listed marijuana-related stock (see 5 Marijuana Stocks Go...

CBIS - Cannabis Science Releases Clinical Drug-Development Pipeline as it Transitions Into Clinical Trials; Right on Time for the Upcoming Global Health Catalyst Summit at Harvard Medical School, May 24-26, 2019

IRVINE, CA, May 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, hits inflection point that translates into an unprecedented progression to clinical trials. With this ch...

CBIS - Independent Valuation of U.S. Patent Number 9,763,991 for Cannabinol (CBN) Initiated as Cannabis Science Negotiates Licensing and Marketing Deals in Canada and the USA to Develop and Sell CBN Products Utilizing the Company's Patent

Cannabis Science’ CBN Patent is for the Treatment of Neurological Conditions, Including Sleep Deprivation, Anxiety, PTSD, and More IRVINE, CA, April 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the devel...
CBIS - Elpasso Farms Just Announced South African Health Products Regulatory Authority (SAHPRA) Awarded Elpasso Farms One of the First Medical Cannabis Cultivation Licenses; Cannabis Science Applauds

IRVINE, CA, April 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC:  CBIS ), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the Company’s strategic partner in South Africa, Elpasso Farms, has...

CBIS - Hemp CBD Uses Proving to be Endless Opportunities for Cannabis Stocks

April 1, 2019 Palm Beach, FL – April 1, 2019 – A recent article in CannabizDaily, an industry newsletter, focused on the reasons hemp biomass, although not a ‘sexy’ label… can be the source of significant revenues in the ever-expanding industry. It sa...

CBIS - New Jersey delays vote on legal weed

New Jersey lawmakers have canceled their planned vote on Monday, April 1, on legalizing the recreational use of marijuana for adults at least 21 years old. More news on: Cronos Group Inc., Canopy Growth Corporation, Tilray, Inc., Healthcare stocks news, Consumer stocks news, News on ETFs...
Previous 10 Next 10